I can see the company making 5 billion realistically in 5 years
With what drugs? B ABSSSI and possible Prurisol are the only drugs that could be on the market by then. Both could pull $1B each and that's being generous for their first or second years on the market. Then you have to factor in the fact that we would be partnered and would never see more than 60% of the revenue (probably more like 30%).
You're just throwing around large numbers which have no basis in reality.